Morishita, Yoshiaki

Patients With Antithyroid Antibodies Are Prone To Develop Destructive Thyroiditis by Nivolumab: A Prospective Study

Kobayashi, T., Iwama, S., Yasuda, Y., Okada, N., Tsunekawa, T., Onoue, T., Takagi, H., Hagiwara, D., Ito, Y., Morishita, Y., et al. (2018) · Journal of the Endocrine Society

Cancer Immunotherapy and BiomarkersThyroid Disorders and Treatments

Cited by 203

De novo triiodothyronine formation from thyrocytes activated by thyroid-stimulating hormone

Citterio, C. E., Veluswamy, B., Morgan, S. J., Galton, V. A., Banga, J. P., Atkins, S., Morishita, Y., Neumann, S., Latif, R., Gershengorn, M. C., et al. (2017) · Journal of Biological Chemistry

Thyroid Disorders and TreatmentsThyroid Cancer Diagnosis and Treatment

Cited by 42

Relationship between the dimerization of thyroglobulin and its ability to form triiodothyronine

Citterio, C. E., Morishita, Y., Dakka, N., Veluswamy, B., & Arvan, P. (2018) · Journal of Biological Chemistry

Thyroid Disorders and TreatmentsThyroid Cancer Diagnosis and Treatment

Cited by 34